A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty

References

• HeijlALeskeMCBengtssonBReduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma TrialArch Ophthalmol2002120101268127912365904
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJOcular Hypertension Treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucomaArch Ophthalmol2002120670171312049574
   PubMed Web of Science ®Google Scholar
• LeskeMCHeijlAHusseinMFactors for glaucoma progression and the effect of treatment: the early manifest glaucoma trialArch Ophthalmol20031211485612523884
   PubMedGoogle Scholar
• The Advanced Glaucoma Intervention Study (AGIS): 7The relationship between control of intraocular pressure and visual field deterioration. AGIS investigatorsAm J Ophthalmol2000130442944011024415
   PubMed Web of Science ®Google Scholar
• LeePPWaltJWRosenblattLCSiegartelLRSternLSGlaucoma CareSGAssociation between intraocular pressure variation and glaucoma progression: data from a United States chart reviewAm J Ophthalmol2007144690190717919446
   PubMed Web of Science ®Google Scholar
• MuschDCGillespieBWNiziolLMLichterPRVarmaRCigtsSGIntraocular pressure control and long-term visual field loss in the collaborative initial glaucoma treatment studyOphthalmology201111891766177321600658
   PubMed Web of Science ®Google Scholar
• StewartWCKolkerAESharpeEDFactors associated with long-term progression or stability in primary open-angle glaucomaAm J Ophthalmol200013027427911020404
   PubMed Web of Science ®Google Scholar
• FingeretMMancilGLBaileyILOptometric Clinical Practice Guideline. Care of the Patient with Open Angle GlaucomaSt. Louis, MOAmerican Optometric Association2010 Available from: http://www.aoa.org/documents/optometrists/CPG-9.pdfAccessed March 6, 2017
   Google Scholar
• PrumBERosenbergLFGeddeSJPrimary open-angle glaucoma preferred practice pattern® guidelinesOphthalmology20161231P41P11126581556
   PubMed Web of Science ®Google Scholar
• CairnsJETrabeculectomy preliminary report of a new methodAm J Ophthalmol19686646736794891876
   PubMed Web of Science ®Google Scholar
• RazeghinejadMRFudembergSJSpaethGLThe changing conceptual basis of trabeculectomy: a review of past and current surgical techniquesSurv Ophthalmol201257112522137574
   PubMed Web of Science ®Google Scholar
• DeBryPWPerkinsTWHeatleyGKaufmanPBrumbackLCIncidence of late-onset bleb-related complications following trabeculectomy with mitomycinArch Ophthalmol2002120329730011879132
   PubMed Web of Science ®Google Scholar
• PoulsenEAllinghamRCharacteristics and risk factors of infections after glaucoma filtering surgeryJ Glaucoma20009643844311131749
   PubMed Web of Science ®Google Scholar
• JampelHMuschDGillespieBLichterPWrightMGuireKPerioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS)Am J Ophthalmol20051401162215939389
   PubMed Web of Science ®Google Scholar
• MatlachJDhillonCHainJSchlunckGGrehnFKlinkTTrabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trialActa Ophthalmol201593875376125847610
   PubMed Web of Science ®Google Scholar
• BullHvon WolffKKörberNTetzMThree-year canaloplasty outcomes for the treatment of open-angle glaucoma: European study resultsGraefes Arch Clin Exp Ophthalmol2011249101537154521732110
   PubMed Web of Science ®Google Scholar
• BrusiniPCanaloplasty in open-angle glaucoma surgery: a four-year follow-upScientificWorldJournal2014162014 469609
   Google Scholar
• BrusiniPCaramelloGBenedettiSTosoniCCanaloplasty in open-angle glaucoma: mid-term results from a multicenter studyJ Glaucoma201425403407
   Web of Science ®Google Scholar
• GandolfiSAUngaroNGhirardiniSTardiniMGMoraPComparison of surgical outcomes between canaloplasty and Schlemm’s canal scaffold at 24 months’ follow-upJ Ophthalmol20162016341046926989497
   PubMed Web of Science ®Google Scholar
• GrieshaberMCPienaarAOlivierJStegmannRCanaloplasty for primary open-angle glaucoma: long-term outcomeBr J Ophthalmol201094111478148220962352
   PubMed Web of Science ®Google Scholar
• LewisRAvon WolffKTetzMCanaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucomaJ Cataract Refract Surg201137468269021420593
   PubMed Web of Science ®Google Scholar
• RulliEBiagioliERivaIEfficacy and safety of trabeculectomy vs. nonpenetrating surgical procedures: a systematic review and meta-analysisJAMA Ophthalmol2013131121573158224158640
   PubMed Web of Science ®Google Scholar
• LinZXuSHuangSZhangXZhongYComparison of canaloplasty and trabeculectomy for open angle glaucoma: a meta-analysisInt J Ophthalmol20169121814181928003985
   PubMed Web of Science ®Google Scholar
• MatlachJFreibergFJLeippiSGrehnFKlinkTComparison of phacotrabeculectomy versus phacocanaloplasty in the treatment of patients with concomitant cataract and glaucomaBMC Ophthalmol201313123360243
   PubMed Web of Science ®Google Scholar
• KlinkTSauerJKörberNJQuality of life following glaucoma surgery: canaloplasty versus trabeculectomyClin Ophthalmol2015971625565763
   PubMed Web of Science ®Google Scholar
• SchoenbergEDChaudhryALChodRZurakowskiDAyyalaRSComparison of surgical outcomes between phacocanaloplasty and phacotrabeculectomy at 12 months’ follow-up: a longitudinal cohort studyJ Glaucoma201524754354924240873
   PubMed Web of Science ®Google Scholar
• LewisRAvon WolffKTetzMCanaloplasty: circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysisJ Cataract Refract Surg20073371217122617586378
   PubMed Web of Science ®Google Scholar
• ShingletonBTetzMKorberNCircumferential viscodilation and tensioning of Schlemm canal (canaloplasty) with temporal clear corneal phacoemulsification cataract surgery for open-angle glaucoma and visually significant cataract: one-year resultsJ Cataract Refract Surg200834343344018299068
   PubMed Web of Science ®Google Scholar
• KhaimiMACanaloplasty: a minimally invasive and maximally effective glaucoma treatmentJ Ophthalmol2015201548506526495135
   PubMed Web of Science ®Google Scholar
• RekasMByszewskaAPetzKWierzbowskaJJünemannACanaloplasty versus non-penetrating deep sclerectomy – a prospective, randomised study of the safety and efficacy of combined cataract and glaucoma surgery; 12-month follow-upGraefes Arch Clin Exp Ophthalmol2015253459159925795059
   PubMed Web of Science ®Google Scholar
• ArthurSNCantorLBWuDunnDEfficacy, safety, and survival rates of IOP lowering effect of phacoemulsification alone or combined with canaloplasty in glaucoma patientsJ Glaucoma201423531632023377581
   PubMed Web of Science ®Google Scholar
• AyyalaRSChaudhryALOkogbaaCBZurakowskiDComparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months’ follow-upOphthalmology2011118122427243321856008
   PubMed Web of Science ®Google Scholar
• TetzMKoerberNShingletonBJPhacoemulsification and intraocular lens implantation before, during, or after canaloplasty in eyes with open-angle glaucoma: 3-year resultsJ Glaucoma201524318719423429620
   PubMed Web of Science ®Google Scholar
• CaginiCPeruzziCFioreTSpadeaLLipperaMLipperaSCanaloplasty: current value in the management of glaucomaJ Ophthalmol20162016708047527239337
   PubMed Web of Science ®Google Scholar
• McGheeCNDeanSDanesh-MeyerHLocally administered ocular corticosteroids: benefits and risksDrug Saf2002251335511820911
   PubMed Web of Science ®Google Scholar
• ClarkAFWilsonKde KaterAWAllinghamRRMcCartneyMDDexamethasone-induced ocular hypertension in perfusion-cultured human eyesInvest Ophthalmol Vis Sci1995364784897843916
   PubMed Web of Science ®Google Scholar
• RajpalRKDigbyDD’AversaGMahFHollanderDAConwayTIntraocular pressure elevations with loteprednol etabonate: a retrospective chart reviewJ Ocul Pharmacol Ther201127330530821574815
   PubMed Web of Science ®Google Scholar
• PleyerUUrsellPGRamaPIntraocular pressure effects of common topical steroids for post-cataract inflammation: are they all the same?Ophthalmol Ther201322557225135807
   PubMedGoogle Scholar
• YablonskiMEBurdeRMKolkerAEBeckerBCataracts induced by topical dexamethasone in diabeticsArch Ophthalmol1978963474476629687
   PubMedGoogle Scholar
• KerseyJPBroadwayDCCorticosteroid-induced glaucoma: a review of the literatureEye200620440741615877093
   PubMed Web of Science ®Google Scholar
• BhardwajYRPareekAJainVKishoreDChemical delivery systems and soft drugs: retrometabolic approaches of drug designSaudi Pharm J201422429030225161372
   PubMed Web of Science ®Google Scholar
• HochhausGChenLDerendorfHPharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogsJ Pharm Sci19928112121012151491342
   PubMed Web of Science ®Google Scholar
• BodorNLoftssonTWuWMMetabolism, distribution, and transdermal permeation of a soft corticosteroid, loteprednol etabonatePharm Res1992910127512781448425
   PubMed Web of Science ®Google Scholar
• DruzgalaPWuWMBodorNOcular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyesCurr Eye Res199110109339371959381
   PubMed Web of Science ®Google Scholar
• WuWHuangFLeeYBuchwaldPBodorNPharmacokinetics of the sequential metabolites of loteprednol etabonate in ratsJ Pharm Pharmacol200860329129718284808
   PubMed Web of Science ®Google Scholar
• HowesJNovackGDFailure to detect systemic levels, and effects of loteprednol etabonate and its metabolite, PJ-91, following chronic ocular administrationJ Ocul Pharmacol Ther19981421531589572541
   PubMed Web of Science ®Google Scholar
• StewartRHorwitzBHowesJNovackGDHartKDouble-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol etabonate post-operative inflammation study group 1J Cataract Refract Surg19982411148014899818338
   PubMed Web of Science ®Google Scholar
• A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The loteprednol etabonate postoperative inflammation study group 2Ophthalmology19981059178017869754192
   PubMed Web of Science ®Google Scholar
• ZhangQ-SWangXWangZ-HZhangS-ZWangLXuW-XInfluence of topical Lotemax on intraocular pressure following excimerChin J Exp Ophthalmol2013316551554
   Google Scholar
• GaoDHLiKJLuHClinical observations on the effect of Lotemax on changes in intra-ocular pressure after LASEK [sic: LASIK]Int J Ophthalmol2010109806807
   Google Scholar
• WuJSZhongXWZhangXXLiuQA randomized controlled study on the application of 0.5% loteprednol etabonate eye drops after LASIK surgeryChin J Exp Ophthalmol2012307641645
   Google Scholar
• MifflinMDLeishmanLLChristiansenSMSikderSHsuMMoshirfarMUse of loteprednol for routine prophylaxis after photo-refractive keratectomyClin Ophthalmol2012665365922570546
   PubMedGoogle Scholar
• SheppardJDComstockTLCavetMEImpact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressureAdv Ther201633453255226984315
   PubMed Web of Science ®Google Scholar
• BartlettJDHorwitzBLaibovitzRHowesJFIntraocular pressure response to loteprednol etabonate in known steroid respondersJ Ocul Pharmacol1993921571658345288
   PubMedGoogle Scholar
• HollandEJDjalilianARSandersonJPAttenuation of ocular hypertension with the use of topical loteprednol etabonate 0.5% in steroid responders after corneal transplantationCornea200928101139114319770719
   PubMed Web of Science ®Google Scholar
• LaneSSHollandEJLoteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgeryJ Cataract Refract Surg201339216817323232255
   PubMed Web of Science ®Google Scholar
• ThanathaneeOSriphonPAnutarapongpanOA randomized controlled trial comparing dexamethasone with loteprednol etabonate on postoperative photorefractive keratectomyJ Ocular Pharmacol Ther2015313165168
   Web of Science ®Google Scholar
• Loteprednol Etabonate US Uveitis Study GroupControlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitisAm J Ophthalmol199912753754410334346
   PubMed Web of Science ®Google Scholar
• WhiteEMMacyJIBatemanKMComstockTLComparison of the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitisCurr Med Res Opin20082428729618062846
   PubMed Web of Science ®Google Scholar
• ChenMGongLSunXA multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunc-tivitisCurr Med Res Opin20122838539422256909
   PubMed Web of Science ®Google Scholar
• HollandEJBartlettJDPaternoMRUsnerDWComstockTLEffects of loteprednol/tobramycin versus dexamethasone/tobramycin on intraoc-ular pressure in healthy volunteersCornea2008271505518245967
   PubMed Web of Science ®Google Scholar
• WangQHarasymowyczPShort-term intraocular pressure elevations after combined phacoemulsification and implantation of two trabecular micro-bypass stents: prednisolone versus loteprednolJ Ophthalmol2015201534145026266045
   PubMed Web of Science ®Google Scholar
• RebenitschRLBrownENBinderNREffect of topical loteprednol on intraocular pressure after selective laser trabeculoplasty for open-angle glaucomaOphthalmol Ther20132211312025135811
   PubMedGoogle Scholar
• International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonized tripartite guideline: guideline for good clinical practiceJ Postgrad Med2001471455011590294
   PubMedGoogle Scholar
• KhaimiMACanaloplasty using iTrack 250 microcatheter with suture tensioning on schlemm’s canalMiddle East Afr J Ophthalmol200916312712920142977
   PubMedGoogle Scholar
• RajpalRKRoelLSiou-MermetRErbTEfficacy and safety of loteprednol etabonate 0.5% gel in the treatment of ocular inflammation and pain after cataract surgeryJ Cataract Refract Surg201339215816723218817
   PubMed Web of Science ®Google Scholar
• ComstockTLPaternoMRSinghAErbTDavisESafety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgeryClin Ophthalmol2011517718621383946
   PubMedGoogle Scholar
• FongRLeitritzMSiou-MermetRErbTLoteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trialClin Ophthalmol201261113112422888209
   PubMedGoogle Scholar
• VoykovBBlumenstockGLeitritzMDimopoulosSAlnahrawyOTreatment efficacy and safety of canaloplasty for open-angle glaucoma after 5 yearsClin Exp Ophthalmol201543876877125952140
   PubMed Web of Science ®Google Scholar
• YanXLiMChenZZhuYSongYZhangHSchlemm’s canal and trabecular meshwork in eyes with primary open angle glaucoma: a comparative study using high-frequency ultrasound biomicroscopyPLoS One2016111e014582426726880
   PubMed Web of Science ®Google Scholar
• HongJXuJWeiASpectral-domain optical coherence tomographic assessment of Schlemm’s canal in Chinese subjects with primary open-angle glaucomaOphthalmology2013120470971523352198
   PubMed Web of Science ®Google Scholar
• HannCRVercnockeAJBentleyMDJorgensenSMFautschMPAnatomic changes in Schlemm’s canal and collector channels in normal and primary open-angle glaucoma eyes using low and high perfusion pressuresInvest Ophthalmol Vis Sci20145595834584125139736
   PubMed Web of Science ®Google Scholar
• HuangJCamrasLJYuanFMechanical analysis of rat trabecular meshworkSoft Matter201511142857286525710888
   PubMed Web of Science ®Google Scholar
• StamerWThe cell and molecular biology of glaucoma: mechanisms in the conventional outflow pathwayInvest Ophthalmol Vis Sci20125352470247222562843
   PubMed Web of Science ®Google Scholar
• BrubakerRTargeting outflow facility in glaucoma managementSurv Ophthalmol200348Suppl 1S17S2012852430
   PubMed Web of Science ®Google Scholar
• Levkovitch-VerbinHHabot-WilnerZBurlaNIntraocular pressure elevation within the first 24 hours after cataract surgery in patients with glaucoma or exfoliation syndromeOphthalmology2008115110410817561259
   PubMed Web of Science ®Google Scholar
• GuptaAVernonSAIs the 1-day postoperative IOP check needed post uncomplicated phacoemulsification in patients with glaucoma and ocular hypertension?Eye201529101299130725697456
   PubMed Web of Science ®Google Scholar
• ChenPPLinSCJunkAKRadhakrishnanSSinghKChenTCThe effect of phacoemulsification on intraocular pressure in glaucoma patients: a report by the American Academy of OphthalmologyOphthalmology201512271294130725943711
   PubMed Web of Science ®Google Scholar
• NovackGDHowesJCrockettRSSherwoodMBChange in intraocular pressure during long-term use of loteprednol etabonateJ Glaucoma1998742662699713785
   PubMed Web of Science ®Google Scholar
• PriceMOFengMTScanameoAPriceFWLoteprednol etabonate 0.5% gel vs. prednisolone acetate 1% solution after descemet membrane endothelial keratoplasty: prospective randomized trialCornea201534885385826020827
   PubMed Web of Science ®Google Scholar
• LiWTLiHWeiJClinical study on the application of 5 g/L loteprenol etabonate ophthalmic suspension after LASIKInt J Ophthalmol201010917921793
   Google Scholar
• CoffeyMJDecoryHHLaneSSDevelopment of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic dropClin Ophthalmol2013729921223430378
   PubMedGoogle Scholar
• BrandãoLMGrieshaberMCUpdate on minimally invasive glaucoma surgery (MIGS) and new implantsJ Ophthalmol2013201370591524369494
   PubMed Web of Science ®Google Scholar
• GrieshaberMCSchoetzauAFlammerJOrgülSPostoperative microhyphema as a positive prognostic indicator in canaloplastyActa Ophthalmol201391215115622151545
   PubMed Web of Science ®Google Scholar